The Pharmacokinetics of Double Boosted Protease Inhibitors in Antiretroviral-naive HIV-1 Infected Patients
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
Treatment with only protease inhibitors might benefit HIV patients. Laboratory data have
shown that the combination of saquinavir with lopinavir and ritonavir may a good regimen.
This study will explore this idea.
Phase:
Phase 2
Details
Lead Sponsor:
The HIV Netherlands Australia Thailand Research Collaboration
Collaborators:
International Antiviral Therapy Evaluation Center Kirby Institute Roche Pharma AG
Treatments:
HIV Protease Inhibitors Lopinavir Protease Inhibitors Ritonavir Saquinavir